Showing results (211-220 of 946) with videos related to
Sort By:
Pageof 95
Annals of Neurology|September 1, 1994
Glutathione-related enzymes in brain in Parkinson's diseaseJ Sian, D T Dexter, A J Lees, et al.European Journal of Pharmacology|May 31, 1990
1-Methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine (2'-methyl-MPTP) is less neurotoxic than MPTP in the common marmosetS Rose, M Nomoto, E A Jackson, et al.Neuroscience Letters|May 19, 1987
Analogues of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine as monoamine oxidase substrates: a second ring is not necessaryC Gibb, J Willoughby, V Glover, et al.Journal of Neurology, Neurosurgery, and Psychiatry|July 1, 1988
Leukocyte glutamate dehydrogenase activity in patients with degenerative neurological disordersD Aubby, H K Saggu, P Jenner, et al.European Neurology|January 1, 1987
Single-dose studies of a slow-release preparation of levodopa and benserazide (Madopar HBS) in Parkinson's diseaseM H Marion, F Stocchi, S L Malcolm, et al.Journal of Neurochemistry|March 1, 1990
Mitochondrial complex I deficiency in Parkinson's diseaseA H Schapira, J M Cooper, D Dexter, et al.Neuropharmacology|May 1, 1984
Behavioural and biochemical alterations in the function of dopamine receptors following repeated administration of L-DOPA to ratsM D Hall, D R Cooper, S Fleminger, et al.Movement Disorders : Official Journal of the Movement Disorder Society|September 1, 1996
Reversal of behavioural abnormalities by fetal allografts in a novel rat model of striatonigral degenerationG K Wenning, R Granata, P M Laboyrie, et al.Neuroscience Letters|September 7, 1984
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the common marmosetP Jenner, N M Rupniak, S Rose, et al.Psychopharmacology|January 1, 1991
Motor activity following the administration of selective D-1 and D-2 dopaminergic drugs to normal common marmosetsP A Löschmann, L A Smith, K W Lange, et al.Pageof 95